Chavarría Piudo, Natalia http://orcid.org/0009-0000-5501-4432
Blancas, Isabel
González Flores, Encarna
Henao Carrasco, Fernando
López Álvarez, Pilar
Morales Pancorbo, David
Gámez Casado, Salvador
Lomas Garrido, María de la Cabeza
Rodríguez García, José Manuel
Martínez Guisado, Antonia
Sánchez Vega, Adrián
Ruíz Borrego, Manuel
Funding for this research was provided by:
Pfizer
Article History
Received: 31 January 2024
Accepted: 26 April 2024
First Online: 3 June 2024
Declarations
:
: Natalia Chavarría Piudo: Consultant or Advisory Role: Novartis, Pfizer, Seagen, Gilead, Daiichi Sankyo. Speaking: Pfizer, Novartis, Roche, Seagen, Grunenthal, Eisai, Gilead, Daiichi Sankyo. Travel-accommodation-inscription: Pfizer, Novartis, Roche, Seagen, Gilead, Daiichi-AZ. Grant support: none. Isabel Blancas reports grants and research support to the Institution from Agendia, AstraZeneca, Lilly, Pfizer and Roche, honoraria and advisor collaboration from AstraZeneca, Bristol-Myers Squibb, Celgene, Daiichi Sankyo, Eisai, Gilead, Grünenthal, Lilly, MSD, Novartis, Pfizer, Pierre-Fabre, Roche, Seagen and Veracyte, support for attending meetings and/or travel from AstraZeneca, Bristol-Myers Squibb, Daiichi Sankyo, Lilly, Novartis, Pfizer, Pierre-Fabre and Roche. Encarna González Flores: Consultant or Advisory Role: Novartis, Pfizer, Seagen, Gilead, Daiichi Sankyo. Speaking: Pfizer, Novartis, Roche, Seagen, Grunenthal, Eisai, Gilead, Daiichi Sankyo. Travel-accommodation-inscription: Pfizer, Novartis, Roche, Seagen, Gilead, Daiichi-AZ. Grant support: none Fernando Henao Carrasco: Speaker grant from Pfizer, Novartis, Astra Zeneca-Daiichi, Pierre Fabre. Advisory board fees from MSD, Novartis. Travel funds from Pfizer. Maria de la Cabeza Lomas Garrido: Relevant financial activities outside the submitted work. Adviser: Astra Zeneca-Daiichi, Speaker: Novartis, Astra Zeneca-Daiichi, Phaiser, Lilly. Intellectual Property-Patents & Copyrights: No. Jose Manuel Rodríguez García: Scientific Consultancy role (speaker and advisory role) GSK, Grünenthal, Novartis, Servier, Prostrakan, Roche, BMS, Merck, MSD. Participation in clinical trials: Lilly, GSK, Novartis, Pfizer. Manuel Ruíz Borrego: Speaker grant from Pfizer, Novartis, Astra Zeneca-Daiichi, Pierre Fabre. Advisory board fees from MSD, Novartis. Travel funds from Pfizer. The other authors declare no conflicts of interest.
: It is a database review of medical records, an observational study. The study protocol was approved by the Ethics Committee of the Hospital Virgen Macarena – Virgen del Rocio of Sevilla on July 28, 2020.